BioCentury
ARTICLE | Company News

Meda, Mylan deal

April 7, 2014 7:00 AM UTC

Specialty pharma company Meda disclosed that its board rejected a proposal from generics company Mylan to "combine the two businesses." Meda makes specialty products, OTC drugs and branded generics. T...